These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11111016)

  • 1. Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors.
    Desai DC; O'Dorisio TM; Schirmer WJ; Jung SS; Khabiri H; Villanueva V; Martin EW
    Regul Pept; 2001 Jan; 96(3):113-7. PubMed ID: 11111016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institution.
    Engelman ES; Leon-Ferre R; Naraev BG; Sharma N; Sun S; O'Dorisio TM; Howe J; Button A; Zamba G; Halfdanarson TR
    Pancreas; 2014 Mar; 43(2):219-25. PubMed ID: 24518499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors.
    Strosberg D; Schneider EB; Onesti J; Saunders N; Konda B; Shah M; Dillhoff M; Schmidt CR; Shirley LA
    Ann Surg Oncol; 2018 Nov; 25(12):3613-3620. PubMed ID: 30182331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional versus Drug-Eluting Bead Transarterial Chemoembolization for Neuroendocrine Tumor Liver Metastases.
    Makary MS; Kapke J; Yildiz V; Pan X; Dowell JD
    J Vasc Interv Radiol; 2016 Sep; 27(9):1298-1304. PubMed ID: 27499157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid rise in circulating pancreastatin in response to somatostatin analogue therapy is associated with poor survival in patients with neuroendocrine tumours.
    Stronge RL; Turner GB; Johnston BT; McCance DR; McGinty A; Patterson CC; Ardill JE
    Ann Clin Biochem; 2008 Nov; 45(Pt 6):560-6. PubMed ID: 18782815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors.
    Strosberg JR; Choi J; Cantor AB; Kvols LK
    Cancer Control; 2006 Jan; 13(1):72-8. PubMed ID: 16508629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: a prospective randomized study.
    Maire F; Lombard-Bohas C; O'Toole D; Vullierme MP; Rebours V; Couvelard A; Pelletier AL; Zappa M; Pilleul F; Hentic O; Hammel P; Ruszniewski P
    Neuroendocrinology; 2012; 96(4):294-300. PubMed ID: 22507901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors.
    Perry LJ; Stuart K; Stokes KR; Clouse ME
    Surgery; 1994 Dec; 116(6):1111-6; discussion 1116-7. PubMed ID: 7985095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors.
    Clouse ME; Perry L; Stuart K; Stokes KR
    Digestion; 1994; 55 Suppl 3():92-7. PubMed ID: 7698544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Serum Pancreastatin Is an Indicator of Hepatic Metastasis in Patients With Small Bowel Neuroendocrine Tumors.
    Khan TM; Garg M; Warner RR; Uhr JH; Divino CM
    Pancreas; 2016 Aug; 45(7):1032-5. PubMed ID: 26684860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver (RETNET): study protocol for a randomized controlled trial.
    Chen JX; Wileyto EP; Soulen MC
    Trials; 2018 Jul; 19(1):390. PubMed ID: 30016989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors.
    Diamandidou E; Ajani JA; Yang DJ; Chuang VP; Brown CA; Carrasco HC; Lawrence DD; Wallace S
    AJR Am J Roentgenol; 1998 Feb; 170(2):339-44. PubMed ID: 9456942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic neuroendocrine metastases: chemo- or bland embolization?
    Pitt SC; Knuth J; Keily JM; McDermott JC; Weber SM; Chen H; Rilling WS; Quebbeman EJ; Agarwal DM; Pitt HA
    J Gastrointest Surg; 2008 Nov; 12(11):1951-60. PubMed ID: 18709512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial.
    Sanz-Altamira PM; Spence LD; Huberman MS; Posner MR; Steele G; Perry LJ; Stuart KE
    Dis Colon Rectum; 1997 Jul; 40(7):770-5. PubMed ID: 9221850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is surgery indicated for patients with symptomatic nonfunctioning pancreatic neuroendocrine tumor and unresectable hepatic metastases?
    Hung JS; Chang MC; Lee PH; Tien YW
    World J Surg; 2007 Dec; 31(12):2392-7. PubMed ID: 17960455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic artery chemoembolization in 122 patients with metastatic carcinoid tumor: lessons learned.
    Bloomston M; Al-Saif O; Klemanski D; Pinzone JJ; Martin EW; Palmer B; Guy G; Khabiri H; Ellison EC; Shah MH
    J Gastrointest Surg; 2007 Mar; 11(3):264-71. PubMed ID: 17458596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic alternatives in metastatic neuroendocrine tumors.
    Miller CA; Ellison EC
    Surg Oncol Clin N Am; 1998 Oct; 7(4):863-79. PubMed ID: 9735138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-arterial hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II study.
    Fiorentini G; Rossi S; Bonechi F; Vaira M; De Simone M; Dentico P; Bernardeschi P; Cantore M; Guadagni S
    J Chemother; 2004 Jun; 16(3):293-7. PubMed ID: 15330328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoembolization of hepatic metastases from intestinal neuroendocrine tumours.
    Kirchhoff T; Chavan A; Galanski M
    Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):141-3. PubMed ID: 10741925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcomas metastatic to the liver: response and survival after cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol chemoembolization.
    Rajan DK; Soulen MC; Clark TW; Baum RA; Haskal ZJ; Shlansky-Goldberg RD; Freiman DB
    J Vasc Interv Radiol; 2001 Feb; 12(2):187-93. PubMed ID: 11265882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.